Logo image of LFCR

LIFECORE BIOMEDICAL INC (LFCR) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:LFCR - US5147661046 - Common Stock

8.09 USD
-0.16 (-1.94%)
Last: 12/30/2025, 8:00:03 PM
7.76 USD
-0.33 (-4.08%)
After Hours: 12/30/2025, 8:00:03 PM
Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to LFCR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.93. This target is 10.32% above the current price.
LFCR was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about LFCR.
In the previous month the buy percentage consensus was at a similar level.
LFCR was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

LFCR Historical Analyst RatingsLFCR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 8.097.588.938.9310.50 - -6.37% 10.32% 10.32% 29.79%

Related screens

LFCR Current Analyst RatingLFCR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-09-04 Keybanc Initiate Sector Weight
2025-05-21 William Blair Initiate Outperform
2025-01-03 Stephens & Co. Reiterate Equal-Weight -> Equal-Weight
2024-11-22 Craig-Hallum Maintains Buy -> Buy
2024-09-05 Craig-Hallum Initiate Buy
2024-08-28 Barrington Research Downgrade Outperform -> Market Perform
2023-09-01 Barrington Research Maintains Outperform -> Outperform
2023-09-01 Stephens & Co. Maintains Equal-Weight -> Equal-Weight
2023-06-02 Barrington Research Maintains Outperform -> Outperform
2023-05-24 Barrington Research Maintains Outperform -> Outperform
2023-03-21 Barrington Research Maintains Outperform
2023-03-20 Barrington Research Maintains Outperform
2023-03-20 Stephens & Co. Downgrade Overweight -> Equal-Weight
2023-03-17 Stephens & Co. Reiterate Overweight

LIFECORE BIOMEDICAL INC / LFCR FAQ

Can you provide the average price target for LIFECORE BIOMEDICAL INC stock?

11 analysts have analysed LFCR and the average price target is 8.93 USD. This implies a price increase of 10.32% is expected in the next year compared to the current price of 8.09.


What is the consensus rating for LIFECORE BIOMEDICAL INC (LFCR) stock?

The consensus rating for LIFECORE BIOMEDICAL INC (LFCR) is 78.1818 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed LIFECORE BIOMEDICAL INC (LFCR)?

The number of analysts covering LIFECORE BIOMEDICAL INC (LFCR) is 11.